Diary - News
All news Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
Darmstadt, Germany, December 10, 2018 – Merck, a leading science and technology company and leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.